The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

Pfizer's stock experienced a notable decline on Friday at the New York Stock Exchange, falling 1.6% to $26.03 per share following news of a $59.7 million settlement payment. The settlement stems from ...

Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...

Pfizer Inc (NYSE:PFE ... Like A Toilet' While On His Death Bed — But She Clar Must Read: New York Community Bancorp Stock Halted After News Of Bank Seeking Capital Infusion, Shares Down 40% ...

Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...

A Wall St. street sign is seen near the New York Stock Exchange (NYSE) in New York City, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo The tepid reception to Venture Global's ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...